Molecular mechanism of substrate transport by human peroxisomal ABCD3. [PDF]
Gupta M +7 more
europepmc +1 more source
X-Linked Adrenoleukodystrophy in a Moroccan Patient: Genetic Diagnosis Leads to Presymptomatic Testing and Family Counseling. [PDF]
Mansouri M +7 more
europepmc +1 more source
CSF and plasma neuro-biomarker dynamics after gene therapy for cerebral adrenoleukodystrophy. [PDF]
Lund TC +5 more
europepmc +1 more source
Adrenoleukodystrophy in adults: phenotypic characterisation and natural history in a large cohort. [PDF]
Benzoni C +12 more
europepmc +1 more source
Twenty years of misdiagnosis of X-linked adrenoleukodystrophy: a case report. [PDF]
Xia D +5 more
europepmc +1 more source
A scoping review of stem cell models of leukodystrophies: advances in understanding pathophysiological mechanisms. [PDF]
Chapleau A +3 more
europepmc +1 more source
Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy. [PDF]
Bougnères P, Le Stunff C.
europepmc +1 more source
Related searches:
Novel ABCD1 gene mutations in Iranian pedigrees with X-linked adrenoleukodystrophy
Journal of Pediatric Endocrinology and Metabolism, 2019Background X-linked adrenoleukodystrophy (X-ALD), the most common peroxisomal disorder, is caused by mutations in the ABCD1 gene located on Xq28. X-ALD is characterized by a spectrum of different manifestations varying in patients and families.
Babak Emamalizadeh +2 more
exaly +4 more sources
X-linked adrenomyeloneuropathy (X-AMN) is a genetic disorder that primarily affects the adrenal cortex and the nervous system. The disease shows a wide range of phenotypic expression, age of onset, and rate of progression.We present a thalassemic 23-year-old man with X-AMN and multiple endocrine disorders.
P. Triantafyllou +6 more
semanticscholar +3 more sources

